Cytochrome P450 3A inhibition by atazanavir and ritonavir, but not demography or drug formulation, influences saquinavir population pharmacokinetics in human immunodeficiency virus type 1-infected adults - von Hentig, N; Lotsch, J (Antimicrob Agents Chemother, 2009)